Shikiar Asset Management’s Revolution Medicines RVMD Stock Holding History

Shikiar Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.22M	Buy	+33,205	New	+$4.85M	1.57%	16

Other funds holding RVMD

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

WPC

Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return

IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

SCA

Sandy Cove Advisors Hingham, Massachusetts $400M AUM 27.68% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

CPM

Connective Portfolio Management New York $60.1M AUM 88.93% 1-Year Est. Return

Shikiar Asset Management's RVMD Position: Q2 2026 in Review

Shikiar Asset Management opened a new position in Revolution Medicines (RVMD) in Q2 2026: 33,205 shares worth $6.22M. The stake represents 1.57% of the portfolio and ranks #16 among its holdings.

82 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Shikiar Asset Management held 33,205 shares of Revolution Medicines worth $6.22M as of Q2 2026.
Revolution Medicines was a new Shikiar Asset Management position in Q2 2026.
Revolution Medicines made up 1.57% of Shikiar Asset Management's portfolio in Q2 2026, its #16 holding.
82 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Shikiar Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.